New OHSU study maps antibody "hot spots" behind anti‑NMDAR encephalitis. Could change diagnosis and treatment.
In April, the FDA announced an ambitious plan to phase out animal testing requirements for monoclonal antibodies and other therapies in an effort to improve drug safety and reduce R&D costs. The goal ...
BEIJING & PRAGUE--(BUSINESS WIRE)--Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human ...
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...
Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...
The global resurgence of mpox, along with its evolving epidemiology and sustained human-to-human transmission, highlights the need to investigate the human antibody response to key monkeypox virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback